NARA Discovery
NARA Subscribed Scholarly Literature Discovery
Boolean search: climate AND coral · microplastic OR nanoplastic · plastic NOT freshwater · "marine heatwave"
Advanced Search
Topic searches article titles and abstracts. Starts a new search; publisher and year refine it.
Searches article titles and abstracts.
Accepts bare DOI, doi: prefix, or a doi.org URL.
Complete publisher name. Publisher imprints are grouped under their main publisher where applicable.
Exact match by full journal title or ISSN.
–
Refine Results Clear Filters
Collection
NARA Subscribed2
Publisher
Elsevier1
Springer Nature1
Journal
European Journal of Clinical Pharmacology1
Regulatory Toxicology and Pharmacology1
Publication Year
20232
Efe Eworuke results 2 · Newest (Page 1/1, per page 25)
Export CSV Export RIS Export current results · up to 5,000 records
Author: Efe Eworuke ×Clear All Filters
Search Results
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparisonNARA Subscribed
Regulatory Toxicology and Pharmacology · 2023 · Vol. 144 · Academic Press
Fernanda Lacerda da Silva Machado; Martín Cañás; Svetlana V. Doubova; Martín A. Urtasun; Gustavo H. Marín; Claudia Garcia Serpa Osorio-de-Castro; Flavia Caixeta Albuquerque; Tatiane Bonfim Ribeiro; Lisa Pont; José Crisóstomo Landeros; Juan Roldán Saelzer; Dino Sepúlveda Viveros; Angela Acosta; Manuel A. Machado Beltrán; Lily Iracema Gordillo Alas; Lourdes Abigail Orellana Tablas; Ria Benko; Irma Convertino; Marco Bonaso; Marco Tuccori; Ursula Kirchmayer; Saúl E. Contreras Sánchez; L. Yesenia Rodríguez-Tanta; Ysabel Gutierrez Aures; Boya Lin; Golnoosh Alipour-Haris; Efe Eworuke; Luciane Cruz Lopes
View Details View Full Text
A collaborative study of the impact of N-nitrosamines presence and ARB recall on ARB utilization – results from IQVIA™ Disease Analyzer GermanyNARA Subscribed
European Journal of Clinical Pharmacology · 2023 · Vol. 79 · Issue 6 · Springer
Karin Hedenmalm; Chantal Quinten; Xavier Kurz; Marie Bradley; Hana Lee; Efe Eworuke
Purpose Regulators are increasingly concerned with the impact of recalls on drug adherence. In 2018, N-nitrosamines impurities were detected in valsartan containing medical products. Concerned products were immediately recalled in July 2018 by regulatory agencies internationally. In Germany, recalls were issued for valsartan, losartan and irbesartan from July 2018 to March 2019. This study examined angiotensin II receptor bloc...
View Details View Full Text